slv334
Small moleculeexperimental
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Apr 1, 2009 (NCT00735085)
Timeline
2000s
- Jan 1, 2009
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- NeprilysinINHIBITOR
MME inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- slv334
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00735085 | Phase 2 | Apr 1, 2009 | Abbott, IQVIA |
Showing 1 of 1 trials
Page 1 / 1